OTTAWA – Members of the federal government’s COVID-19 vaccine task force are casting worried eyes at the Trump administration’s political push to get a vaccine approved before the U.S. presidential election in November.
Dr. Joanne Langley, the task force co-chair and member Alan Bernstein say they are concerned about “vaccine hesitancy” in Canada, the phenomenon where people have doubts about taking a readily available vaccine because of concerns about its safety.
Langley says that when a vaccine against COVID-19 is eventually found, governments and health-care professionals will have to mount a vigorous information campaign to counter the opposition.
And it won’t help that President Donald Trump has said a pandemic-ending vaccine could be rolled out as soon as October, stoking concern that he is rushing the timeline to further his re-election chances on Nov. 3.
Countering concerns that an apparent hurry to approve a vaccine could spook people out of getting it is an ongoing concern among the approximately one dozen health experts on the government’s vaccine advisory panel.
It’s tasked with recommending which vaccine candidates the government should be spending money on.
Photo credit: AP Photo/Kirsty Wigglesworth, File
News source: The Canadian Press